Getting Ahead of Migraine: Best Practices for Migraine Prevention—Targeting CGRP for Migraine Prevention

Do you know what your migraine patients want most from their migraine treatment? A new class of therapies ‒ anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) ‒ have recently been approved for migraine prevention. Unlike other treatments, anti-CGRP mAbs directly target the mechanism of migraine. Join Dr Cynthia Armand and Dr Carrie Dougherty as they discuss the efficacy, safety, onset of action, and administration of these agents. Strategies for incorporating shared decision-making to guide treatment selection and improve adherence are also reviewed.

Target Audience

This program is designed for neurologists, pain specialists, and other clinicians who treat people with migraines.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • COMPARE the efficacy and safety trial data of CGRP-targeted therapies for migraine prevention
  • IDENTIFY ways to improve medication adherence through shared decision-making

Additional Information

Partner: 
myCME
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit
Course opens: 
02/26/2021
Course expires: 
02/26/2022
Rating: 
0

The faculty have indicated that their financial relationships will not impact their ability to discuss material that is balanced, non-biased, accurate, current, and scientifically rigorous.

Cynthia E. Armand, MD
Assistant Professor of Neurology
Albert Einstein College of Medicine
Fellowship Director
Montefiore Headache Center
Bronx, NY

Dr Armand is on the advisory board for Biohaven Pharmaceuticals.

Carrie Dougherty, MD, FAHS
Associate Professor of Neurology
Program Director, Headache Medicine Fellowship
Assistant Program Director, Neurology Residency
MedStar Georgetown University Hospital
Washington, DC 

Dr. Dougherty has received research grants, paid to the institution, from Amgen Inc. and electroCore, Inc; is on the speakers bureau for Amgen Inc., Biohaven Pharmaceuticals, electroCore, Inc., Eli Lilly and Company, Lundbeck, Novartis Pharmaceuticals Corporation, Teva Pharmaceutical Industries Ltd.; and is a consultant for Allergan, Biohaven Pharmaceuticals, Lundbeck, Novartis Pharmaceuticals Corporation, Magellan Rx Management, Supernus Pharmaceuticals, Inc, and Theranica Bio-Electronics Ltd.

Reviewer
David Myland Kaufman, MD
Professor, The Saul R. Korey Department of Neurology
Professor, Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Dr Kaufman has no relevant conflicts of interest with any ACCME-defined commercial interest during the past 12 months.

Accredited Providers

This educational activity is jointly provided by the Albert Einstein College of Medicine–Montefiore Medical Center and Spire Learning.

AMA PRA Category 1 CreditTM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine–Montefiore Medical Center and Spire Learning. Albert Einstein College of Medicine–Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Albert Einstein College of Medicine–Montefiore Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.50 Category 1 Credit for completing this activity.

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Available Credit

  • 0.50 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through myCME. 

To take this course you will be redirected to myCME's website. You must login or create an account with myCME in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!